Investigating the Effect of Vortioxetine in Adult ADHD Patients

Summary

The purpose is to determine the effect of vortioxetine treatment on ADHD symptoms in adult patients with ADHD in a 12 weeks study.

Timeline

Start

2014-12

Primary completion

2016-09

Completion

2016-09

Outcome

Missed primary endpoint

registry analysis (superiority test); Placebo, Combined vs Vortioxetine 10mg, Combined; p = 0.9723; Mean Difference (Final Values) -0.1 (95% CI -3.6 to 3.5); weighed z-score NCT02327013 ↗

registry analysis (superiority test); Placebo, Combined vs Vortioxetine 20mg, Combined; p = 0.6010; Mean Difference (Final Values) 1.0 (95% CI -2.8 to 4.8); weighed z-score NCT02327013 ↗

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Vortioxetine	Unknown	10 mg	Oral
Subject	Vortioxetine	Unknown	20 mg	Oral

Indications